NVST Earnings

NVST reported its earnings on 2026-02-05, showcasing a revenue of 0.00 against an estimate of 675.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.32 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following NVST's earnings announcement on 2026-02-05, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, NVST's stock price tends to shift by an average of +0.41% in the 10 days leading up to earnings and +4.26% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate NVST’s annual revenue to reach 680.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.94% and EPS estimates Revise Downward by -0.43% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between NVST's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.94%, while EPS estimates moved Revise Downward by -0.43% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NVST's stock price typically moves by +0.41% in the 10 days before its earnings and +4.26% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 680.00M.

The earnings call summary provides a positive outlook with increased guidance for revenue and EPS, stable EBITDA margins, and optimistic market conditions. The Q&A section reinforces this with strong growth in key segments, effective cost management, and strategic market positioning. Despite some uncertainties, such as VBP impacts in China, the overall sentiment is positive, especially with strong performance in consumables and implants. Given the company's market cap, the stock is likely to experience a positive price movement between 2% to 8% over the next two weeks.